Oxytocin nerve terminal desensitization to kappa-opioids at the end of pregnancy.
Douglas
A J
AJ
Department of Physiology, University Medical School, Edinburgh, United Kingdom.
Bicknell
R J
RJ
D000818:Animals; D001575:Benzomorphans / Q000378:metabolism; D004351:Drug Resistance; D004723:Endorphins / Q000502:physiology*; D004744:Enkephalin, Methionine / Q000378:metabolism; D004745:Enkephalins / Q000235:genetics; D005260:Female; D009411:Nerve Endings / Q000378:metabolism* / Q000502:physiology*; D010121:Oxytocin / Q000378:metabolism*; D010904:Pituitary Gland, Posterior / Q000378:metabolism; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000378:metabolism / Q000502:physiology*; D011498:Protein Precursors / Q000235:genetics; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D017473:Receptors, Opioid, kappa / Q000378:metabolism; D012016:Reference Values; D013495:Supraoptic Nucleus / Q000378:metabolism
D001575:Benzomorphans; D004723:Endorphins; D004745:Enkephalins; D011498:Protein Precursors; D012333:RNA, Messenger; D017473:Receptors, Opioid, kappa; D010121:Oxytocin; D004744:Enkephalin, Methionine; C033660:preproenkephalin; C027248:bremazocine